Region:Middle East
Author(s):Rebecca
Product Code:KRAC9730
Pages:82
Published On:November 2025
 Market.png "Middle East Acute External Ventricular Drain (EVD) Market Size")
By Type:The market is segmented into various types of EVDs, including Standard EVD, Adjustable EVD, Antimicrobial EVD, Pediatric EVD, and Others. Among these, the Antimicrobial EVD is gaining traction due to its effectiveness in reducing infection rates, which is a critical concern in neurosurgery. The demand for Adjustable EVDs is also on the rise as they offer flexibility in managing intracranial pressure, catering to a broader range of patient needs. The Standard EVD remains a staple due to its established efficacy and cost-effectiveness. Recent advancements in antimicrobial coatings and customizable drainage systems are further driving adoption in high-risk patient populations .
By End-User:The market is categorized by end-users, including Hospitals, Specialty Neurosurgery Centers, Academic & Research Institutes, Rehabilitation Centers, and Others. Hospitals are the leading end-users due to their comprehensive facilities and the high volume of neurosurgical procedures performed. Specialty Neurosurgery Centers are also significant players, as they focus on advanced surgical techniques and patient care. The demand from Academic & Research Institutes is growing as they contribute to clinical studies and innovations in EVD technology. The increasing number of neurosurgical units and research collaborations in tertiary care hospitals is further expanding the hospital segment’s dominance .
The Middle East Acute External Ventricular Drain (EVD) Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic plc, Johnson & Johnson (DePuy Synthes), Integra LifeSciences Holdings Corporation, Codman & Shurtleff (part of Integra LifeSciences), Natus Medical Incorporated, B. Braun Melsungen AG, Stryker Corporation, Smiths Medical (now part of ICU Medical, Inc.), Medline Industries, LP, ConvaTec Group plc, Fresenius Kabi AG, Terumo Corporation, Avanos Medical, Inc. (formerly Halyard Health), Aesculap, Inc. (a B. Braun company), Merit Medical Systems, Inc. contribute to innovation, geographic expansion, and service delivery in this space.
The future of the Middle East Acute External Ventricular Drain market appears promising, driven by ongoing advancements in medical technology and increasing healthcare investments. As governments prioritize healthcare infrastructure, the demand for EVD systems is expected to rise. Additionally, the integration of artificial intelligence in medical devices will enhance procedural efficiency and patient outcomes. These trends indicate a robust growth trajectory for the EVD market, with a focus on improving access and quality of care across the region.
| Segment | Sub-Segments |
|---|---|
| By Type | Standard EVD Adjustable EVD Antimicrobial EVD Pediatric EVD Others |
| By End-User | Hospitals Specialty Neurosurgery Centers Academic & Research Institutes Rehabilitation Centers Others |
| By Application | Traumatic Brain Injury Subarachnoid Hemorrhage Hydrocephalus Post-Surgical Care Chronic Conditions Others |
| By Material | Silicone Polyurethane Others |
| By Region | GCC Countries Levant Region North Africa |
| By Distribution Channel | Direct Sales Online Sales Distributors Others |
| By Pricing Model | Premium Pricing Competitive Pricing Value-Based Pricing Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Neurosurgeons in Major Hospitals | 60 | Senior Neurosurgeons, Department Heads |
| Hospital Procurement Managers | 50 | Procurement Officers, Supply Chain Managers |
| Medical Device Distributors | 40 | Sales Managers, Regional Distributors |
| Healthcare Policy Makers | 40 | Health Administrators, Policy Analysts |
| Clinical Researchers in Neurosurgery | 45 | Research Scientists, Clinical Trial Coordinators |
The Middle East Acute External Ventricular Drain (EVD) Market is valued at approximately USD 810 million, driven by the rising prevalence of neurological disorders and advancements in medical technology.
What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
